Jan 8, 2020

💉 ~ The danish biotech company Adaptvac, a vaccine developer has secured US patents on the company's platform and all the cancer prevention vaccines being developed on the platform ☠️ ~ | Blogger: [🤜AdaptVac Aps is a danish vaccine manufacturer of vaccines against cancer, malaria and antibiotics for pigs and many other products in full cooperation with scientists from UCPH - some is govt funded🤛] ... This is of course SoTW's own claims after 20 years of research... But, we know, more or less, that HPV, MMR vaccines and the danish childhood immunization program has partnered up with WHO, UN, CDC, ECDC and many more organizations - a conspiracy to commit healthcare fraud or scientific fraud, that has lethal consequences... We know, that, data suppressed by the CDC proved that the MMR vaccine produces a 340% increased risk of autism... We know, that, with aluminum and polysorbate-80 tightly bound in the HPV vaccine, are able to pass freely into the brain across the BBB(Blood Brain Barrier), regardless of the state of health of the BBB, this can explain some of the fainting, seizures, and neurological sequelae that have been reported in teenage girls after they have received the HPV vaccine... And the list goes on and on and (on)... Sooo... Is UCPH (University of Copenhagen), the Rockefeller Complex and Niels Bohr Institute, in bed with the medical-industrial complex (mafia)?... 1000% chance of that... The cancer industry is an unstoppable trillion-dollar killing machine... We know that danish Novo Nordisk A/S, Bayer and U.S. Monsanto Company (partnership & merger) is yet another integrated multinational pharmaceutical- agrochemical and agricultural biotechnology corporation, who has billions in profit, by developing products, that gets people sick, not healthier... |

AdaptVac is a joint-venture between NASDAQ First North listed ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. And we he University of Copenhagen has designed a simple technique that makes it possible to quickly and easily develop a new type of vaccines


Sources: 

https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-s-joint-venture-adaptvac-granted-us-patent-for-its-core-platform-technology,c3002197
https://medwatch.dk/secure/Medicinal___Biotek/article11861704.ece
https://www.snopes.com/fact-check/bad-medicine/
https://vaccinechoicecanada.com/vaccine-ingredients/when-vaccine-ingredients-cross-the-blood-brain-barrier-a-formula-for-disaster/

No comments:

Post a Comment